$POLA
Polar Power, Inc. Stock $pola

$pola Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017325 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$5.587M	$4.190M	$3.709M
YoY Change	30.72%	12.97%	12.74%
Cost Of Revenue	$4.112M	$3.435M	$2.804M
YoY Change	27.98%	22.5%	-16.3%
Gross Profit	$1.475M	$755.0K	$905.0K
YoY Change	39.02%	-16.57%	-1608.33%
Gross Profit Margin	26.4%	18.02%	24.4%
Selling, General & Admin	$1.447M	$1.444M	$1.536M
YoY Change	0.77%	-5.99%	13.78%
% of Gross Profit	98.1%	191.26%	169.72%
Research & Development	$338.0K	$346.0K	$476.0K
YoY Change	-3.43%	-27.31%	-2.86%
% of Gross Profit	22.92%	45.83%	52.6%
Depreciation & Amortization	$110.0K	$116.0K	$135.0K
YoY Change	-14.73%	-14.07%	-10.0%
% of Gross Profit	7.46%	15.36%	14.92%
Operating Expenses	$1.785M	$1.790M	$2.012M
YoY Change	-0.06%	-11.03%	9.35%
Operating Profit	-$310.0K	-$1.035M	-$1.107M
YoY Change	-57.24%	-6.5%	-41.74%
Interest Expense	$126.0K	$78.00K	-$13.00K
YoY Change	800.0%	-700.0%	-35.0%
% of Operating Profit
Other Income/Expense, Net	-$126.0K	-$78.00K
YoY Change	800.0%
Pretax Income	-$436.0K	-$1.113M	-$1.120M
YoY Change	-41.0%	-0.63%	-41.05%
Income Tax
% Of Pretax Income
Net Earnings	-$436.0K	-$1.113M	-$1.120M
YoY Change	-41.0%	-0.63%	-41.05%
Net Earnings / Revenue	-7.8%	-26.56%	-30.2%
Basic Earnings Per Share	$0.03	-$0.09	-$0.10
Diluted Earnings Per Share	$0.03	-$0.09	-$87.58K
COMMON SHARES
Basic Shares Outstanding	12.95M shares	12.95M shares	12.79M shares
Diluted Shares Outstanding	12.95M shares	12.95M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$292.0K	$119.0K	$4.186M
YoY Change	-89.01%	-97.16%	-63.15%
Cash & Equivalents	$292.0K	$119.0K	$4.186M
Short-Term Investments
Other Short-Term Assets	$3.050M	$3.852M	$5.264M
YoY Change	-52.24%	-26.82%	583.64%
Inventory	$17.69M	$16.88M	$10.49M
Prepaid Expenses	$1.050M	$1.852M
Receivables	$3.718M	$3.216M	$3.616M
Other Receivables	$787.0K	$787.0K	$787.0K
Total Short-Term Assets	$25.54M	$24.85M	$24.34M
YoY Change	-1.05%	2.1%	-5.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$505.0K	$421.0K	$1.641M
YoY Change	-34.42%	-74.34%	-40.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$93.00K	$93.00K	$93.00K
YoY Change	0.0%	0.0%	3.33%
Total Long-Term Assets	$2.776M	$2.950M	$1.734M
YoY Change	92.38%	70.13%	-38.94%
TOTAL ASSETS
Total Short-Term Assets	$25.54M	$24.85M	$24.34M
Total Long-Term Assets	$2.776M	$2.950M	$1.734M
Total Assets	$28.31M	$27.80M	$26.07M
YoY Change	3.89%	6.62%	-8.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.429M	$1.024M	$544.0K
YoY Change	958.52%	88.24%	26.51%
Accrued Expenses	$1.959M	$1.994M	$1.902M
YoY Change	8.71%	4.84%	5.08%
Deferred Revenue
YoY Change
Short-Term Debt	$4.927M	$3.010M	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$295.0K	$172.0K	$245.0K
YoY Change	18.95%	-29.8%	-2.0%
Total Short-Term Liabilities	$10.15M	$8.969M	$3.614M
YoY Change	78.92%	148.17%	-19.69%
LONG-TERM LIABILITIES
Long-Term Debt	$8.000K	$33.00K	$205.0K
YoY Change	-94.41%	-83.9%	-60.58%
Other Long-Term Liabilities	$1.527M	$1.729M	$123.0K
YoY Change	3148.94%	1305.69%	-85.0%
Total Long-Term Liabilities	$1.535M	$1.762M	$328.0K
YoY Change	707.89%	437.2%	-75.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.15M	$8.969M	$3.614M
Total Long-Term Liabilities	$1.535M	$1.762M	$328.0K
Total Liabilities	$11.68M	$10.73M	$3.942M
YoY Change	99.32%	172.22%	-32.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$20.66M	-$20.22M
YoY Change	34.28%
Common Stock	$1.000K	$1.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.63M	$17.07M	$22.13M
YoY Change
Total Liabilities & Shareholders Equity	$28.31M	$27.80M	$26.07M
YoY Change	3.89%	6.62%	-8.84%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$436.0K	-$1.113M	-$1.120M
YoY Change	-41.0%	-0.63%	-41.05%
Depreciation, Depletion And Amortization	$110.0K	$116.0K	$135.0K
YoY Change	-14.73%	-14.07%	-10.0%
Cash From Operating Activities	-$1.648M	-$1.156M	-$847.0K
YoY Change	12.57%	36.48%	-74.94%
INVESTING ACTIVITIES
Capital Expenditures	$194.0K		-$8.000K
YoY Change	-2871.43%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$194.0K		-$8.000K
YoY Change	2671.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.015M	$1.064M	-60.00K
YoY Change	-3515.25%	-1873.33%	-100.46%
NET CHANGE
Cash From Operating Activities	-1.648M	-$1.156M	-847.0K
Cash From Investing Activities	-194.0K		-8.000K
Cash From Financing Activities	2.015M	$1.064M	-60.00K
Net Change In Cash	173.0K	-$92.00K	-915.0K
YoY Change	-111.31%	-89.95%
FREE CASH FLOW
Cash From Operating Activities	-$1.648M	-$1.156M	-$847.0K
Capital Expenditures	$194.0K		-$8.000K
Free Cash Flow	-$1.842M	-$1.156M	-$839.0K
YoY Change	26.42%	37.78%	-75.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001622345
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023Q1	POLA	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023Q1	POLA	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37960
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	POLAR POWER, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0479020
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	249 E. Gardena Blvd.
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Gardena
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90248
CY2023Q1	dei	City Area Code CityAreaCode	(310)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	830-9153
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	POLA
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12949550	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	211000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3216000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2230000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	16875000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	15460000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1852000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2629000	usd
CY2023Q1	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd
CY2022Q4	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	787000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	787000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	24849000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	23317000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2436000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	240000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	421000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	538000	usd
CY2023Q1	us-gaap	Deposit Assets DepositAssets	93000	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	93000	usd
CY2023Q1	us-gaap	Assets Assets	27799000	usd
CY2022Q4	us-gaap	Assets Assets	24188000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1024000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	230000	usd
CY2023Q1	us-gaap	Deposits Deposits	2769000	usd
CY2022Q4	us-gaap	Deposits Deposits	2126000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1256000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1231000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	738000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	268000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	172000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	211000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	3010000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1884000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8969000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5950000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	33000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	57000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1729000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	10731000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6007000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12967027	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12949550	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12967027	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12949550	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	37331000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	37331000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20224000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19111000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17477	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	17477	shares
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	40000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	40000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	17068000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	18181000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27799000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24188000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4190000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3709000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3435000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2804000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	755000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	905000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	333000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	405000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	346000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	476000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1111000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1131000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1790000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2012000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1035000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1107000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	78000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	13000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-78000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1113000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1120000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12949550	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12788203	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	18181000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1113000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	17068000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23250000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23250000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1120000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	22130000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	22130000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1113000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1120000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	116000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	135000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	986000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-626000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1415000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1468000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-777000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-742000	usd
CY2023Q1	POLA	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-196000	usd
CY2022Q1	POLA	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-166000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	794000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	216000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	643000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	26000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	25000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	5000	usd
CY2023Q1	POLA	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	-193000	usd
CY2022Q1	POLA	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	-175000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1156000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-847000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1127000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	63000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	60000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1064000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-60000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-92000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-915000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	211000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5101000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	119000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4186000	usd
CY2023Q1	POLA	Initial Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities InitialRecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities	2392000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1113000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1156000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	664000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	17068000	usd
CY2023Q1	POLA	Working Capital WorkingCapital	15880000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zU7vxL2CcJ9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zYvIDwI5Z9N9">Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Material estimates relate to the assumptions made in determining reserves for uncollectible receivables, inventory reserves and returns, impairment analysis of long-term assets, valuation allowance on deferred tax assets, income tax accruals, accruals for potential liabilities and warrant reserves and assumptions made in valuing equity instruments issued for services. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4190000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3709000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4190000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3709000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4190000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3709000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	13870000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	12277000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3005000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3183000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	16875000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	15460000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	102000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	508000	usd
CY2023Q1	POLA	Standard Product Warranty Accrual Provision StandardProductWarrantyAccrualProvision	102000	usd
CY2022	POLA	Standard Product Warranty Accrual Provision StandardProductWarrantyAccrualProvision	508000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_z6eDGAxtax" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zLLXhSTohqbi">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash</i>. The Company maintains cash balances at four banks, with the majority held at one bank located in the U.S. At times, the amount on deposit exceeds the federally insured limits. Management believes that the financial institutions that hold the Company’s cash are financially sound and, accordingly, minimal credit risk exists.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash denominated in Australian Dollars with a U.S. Dollar equivalent of $<span id="xdx_90B_eus-gaap--Cash_iI_pn3n3_c20230331__srt--StatementGeographicalAxis__country--AU_zVfRoQSDhvN5" title="Cash">11</span> and $<span id="xdx_904_eus-gaap--Cash_iI_pn3n3_c20221231__srt--StatementGeographicalAxis__country--AU_zgywGLFLqJG7" title="Cash">8</span> at March 31, 2023 and December 31, 2022, respectively, was held in an account at a financial institution located in Australia. Cash denominated in Romanian Leu with a U.S. Dollar equivalent of $<span id="xdx_90E_eus-gaap--Cash_iI_pn3n3_c20230331__srt--CurrencyAxis__currency--RON_zj4fwfz5rh7l" title="Cash">20</span> and $<span id="xdx_90F_eus-gaap--Cash_iI_pn3n3_c20221231__srt--CurrencyAxis__currency--RON_zuT1bx6VkLn" title="Cash">23</span> at March 31, 2023 and December 31, 2022, respectively, was held in an account at a financial institution located in Romania.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenues. </i>For the three months ended March 31, 2023, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--StatementGeographicalAxis__country--US__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zF2mlJ8Jlwvl" title="Concentration risk">49.5</span>% of revenues was generated from the Company’s largest customer (a Tier-1 telecommunications wireless carrier in the U.S), and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z4Z5ZyAQOJff" title="Concentration risk">26.7</span>% of revenue was generated from the Company’s second largest customer ( a telecommunications customer outside the U.S.). For the three months ended March 31, 2022, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--StatementGeographicalAxis__country--US__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMCFTjtHU8Af" title="Concentration risk">90.2</span>% of revenues was generated from the Company’s largest customer, a Tier-1 telecommunications customer in the U.S. There was no other revenue from customers in excess of 10% of revenues in either period. For the three months ended March 31, 2023 and March 31, 2022, sales to telecommunications customers accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zxQKGKADVvE2" title="Concentration risk">95</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zwtMyknVhDU" title="Concentration risk">99</span>% of total revenues, respectively. For the three months ended March 31, 2023 and March 31, 2022, sales to international customers accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zos7ZaJQfXv" title="Concentration risk">22</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zidSjh0DXyY9" title="Concentration risk">1</span>%, of total revenue, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable</i>. At March 31, 2023, the two largest receivable accounts represented <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zATntfvXn7lj" title="Concentration risk">77</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGfHWgTC8Fwe" title="Concentration risk">11</span>% of the Company’s accounts receivable. <span style="background-color: white">At December 31, 2022, </span>the Company’s largest receivable account represented <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zrBU67Q57Img" title="Concentration risk">90</span>% of the Company’s total accounts receivable. There was no other customer that accounted for more than 10% of the Company’s accounts receivable as of March 31, 2023 or December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable</i>. At March 31, 2023, accounts payable to the Company’s three largest vendors represented <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--LargestVendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zrXukWZte4uk" title="Concentration risk">44%</span>, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--LargestVendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zxIaM60AYyij" title="Concentration risk">6%</span> and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--LargestVendorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zJYyTHYQxTyg" title="Concentration risk">5%</span>, respectively, of the Company’s accounts payable. On December 31, 2022, the three largest accounts payable accounts to the Company’s vendors represented <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestVendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zmuYZyb0aO5" title="Concentration risk">51%</span>, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestVendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_z9LLqa7zalP9" title="Concentration risk">3%</span>, and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestVendorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zIoEsOlTQEX8" title="Concentration risk">3%</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	164122	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	164122	shares
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4300000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4300000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3879000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3762000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	421000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	538000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	116000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	135000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	113000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	130000	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	205000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	268000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	172000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	211000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	33000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	57000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.22
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.22
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	140000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.22
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	24122	shares
CY2022Q4	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	3.13
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	24122	shares
CY2023Q1	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	3.13
CY2023Q1	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	24122	shares
CY2023Q1	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice	3.13
CY2022Q4	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	24122	shares
CY2023Q1	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	24122	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.13
CY2023Q1	POLA	Description Of Warrant Expiration Date DescriptionOfWarrantExpirationDate	expire in July 2025.
CY2023Q1	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue	0	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2596000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	58000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	74000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	84000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	84000	usd
CY2023Q1	POLA	Initial Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities InitialRecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities	2392000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	212000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	175000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	212000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	175000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M12D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0613	pure
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0375	pure
CY2023Q1	POLA	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	2340000	usd
CY2022Q4	POLA	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	2577000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2436000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	240000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	738000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	268000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1729000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2467000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	268000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	651000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	858000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	990000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	168000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2667000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	200000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2467000	usd
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	287000	usd
CY2022Q1	us-gaap	Payments For Rent PaymentsForRent	226000	usd
CY2021	POLA	Employee Retention Credits Wages Percentage EmployeeRetentionCreditsWagesPercentage	0.70	pure
CY2021	POLA	Employee Retention Credits Per Shares EmployeeRetentionCreditsPerShares	7
CY2021Q4	POLA	Expenses Of Employee Retention Credit ExpensesOfEmployeeRetentionCredit	2000000	usd
CY2023Q1	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd
CY2022Q4	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
pola-20230331_pre.xml	Edgar Link	unprocessable
0001493152-23-017325-index-headers.html	Edgar Link	pending
0001493152-23-017325-index.html	Edgar Link	pending
0001493152-23-017325.txt	Edgar Link	pending
0001493152-23-017325-xbrl.zip	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex10-1_002.jpg	Edgar Link	pending
ex10-1_003.jpg	Edgar Link	pending
ex10-1_004.jpg	Edgar Link	pending
ex10-1_005.jpg	Edgar Link	pending
ex10-1_006.jpg	Edgar Link	pending
ex10-1_007.jpg	Edgar Link	pending
ex10-1_008.jpg	Edgar Link	pending
ex10-1_009.jpg	Edgar Link	pending
ex10-1_010.jpg	Edgar Link	pending
ex10-1_011.jpg	Edgar Link	pending
ex10-1_012.jpg	Edgar Link	pending
ex10-1_013.jpg	Edgar Link	pending
ex10-1_014.jpg	Edgar Link	pending
ex10-1_015.jpg	Edgar Link	pending
ex10-1_016.jpg	Edgar Link	pending
ex10-1_017.jpg	Edgar Link	pending
ex10-1_018.jpg	Edgar Link	pending
ex10-1_019.jpg	Edgar Link	pending
ex10-1_020.jpg	Edgar Link	pending
ex10-1_021.jpg	Edgar Link	pending
ex10-1_022.jpg	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-4_001.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pola-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
pola-20230331_cal.xml	Edgar Link	unprocessable
pola-20230331_def.xml	Edgar Link	unprocessable
pola-20230331_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$POLA
Polar Power, Inc. Stock $pola

2023 Q2 Form 10-Q Financial Statement

#000149315223017325 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POLA Polar Power, Inc. Stock $pola

2023 Q2 Form 10-Q Financial Statement

#000149315223017325 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POLA
Polar Power, Inc. Stock $pola